Benign Prostatic Hyperplasia (BPH) is a coincident voyage with the rising number of incidences. So far, the gold-standard treatments are still open prostatectomy (OP) and transurethral resection of the prostate (TURP). However, some studies have confirmed a direct effect of comorbidity on perioperative morbidity and mortality after these procedures. So there is a need to have different surgical options that have long term durable effects.
Docplexus invites you to an interactive LIVE Webinar on 1 st July 2017 at 10.30 am with Dr. Deepak Kirpekar. This webinar session discusses “ Critical Look At Surgical Options for Benign Prostatic Hyperplasia."
